MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

UNBS5162

CAS No. : 956590-23-1

MCE 站：UNBS5162

产品活性：UNBS5162 是一种广谱的趋化因子配体 CXCL 拮抗剂，具有抗肿瘤活性。

研究领域：GPCR/G Protein  |  Immunology/Inflammation  |  Autophagy

作用靶点：CXCR  |  Autophagy

In Vitro: UNBS5162 is a pan-antagonist of CXCL chemokine expression and exhibits weak antiproliferative activity against human cancer cell lines with mean IC₅₀ of 17.9 ?M. UNBS5162 markedly impairs PC-3 tumor cell growth kinetics, without inducing senescence, whereas the reverse feature is observed with respect to DU-145 cells. UNBS5162 is cytotoxic to a range of human cancer cell lines including glioblastoma (Hs683 and U373MG), colorectal (HCT-15 and LoVo), non-small-cell lung (A549) and breast (MCF-7), with IC₅₀s of 0.5-5 ?M. UNBS5162 also markedly increases the levels of expression of LC3-I and LC3-II in human cancer cells. UNBS5162 displays no anti-topoisomerase II activity. Moreover, UNBS5162 induces cancer cell death through lysosomal membrane permeabilization (LMP) in PC3 prostate cancer cells but not in U373 glioblastoma cells, with this LMP process occurring as an UNBS5162-induced decrease in Hsp70 expression. UNBS5162 inhibits the proliferation of esophageal cancer squamous cells via the PI3K/AKT signaling pathway. UNBS5162 downregulates the protein expression of proteins associated with the PI3K/AKT signaling pathway, including the levels of phosphorylated (p)-AKT, p-mechanistic target of rapamycin kinase, ribosomal protein S6 kinase β1 and cyclin D1.

In Vivo: UNBS5162 (20 mg/kg, i.v.) increases the therapeutic benefits of taxol in vivo in the orthotopic human PC-3 prostate cancer model.

相关产品：Bioactive Compound Library Plus  |  GPCR/G Protein Compound Library  |  Immunology/Inflammation Compound Library  |  Anti-Cancer Compound Library  |  Autophagy Compound Library  |  Small Molecule Immuno-Oncology Compound Library  |  Anti-Aging Compound Library  |  Endocrinology Compound Library  |  SB225002  |  Reparixin  |  Motixafortide  |  TAK-779  |  IT1t dihydrochloride  |  NBI-74330  |  Baohuoside I  |  AMD 3465 hexahydrobromide  |  ATI-2341 TFA  |  CXCR2-IN-1  |  FC131 TFA  |  ALX 40-4C Trifluoroacetate  |  SRT3109  |  PS372424 hydrochloride  |  SRT3190  |  VUF11207 fumarate  |  CXCR7 modulator 1  |  Nicotinamide N-oxide  |  SB-265610  |  Antileukinate  |  Corydalmine  |  CTCE-9908  |  MSX-127  |  MSX-130

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。